<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Levitra; Vardenafil" /><meta name="IX" content="Levitra; Vardenafil" /><title>Levitra®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="127955.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="127955.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=127955.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2074.htm">7 Obstetrics, gynaecology, and urinary-tract disorders</a> &gt; <a href="4614.htm">7.4 Drugs for genito-urinary disorders</a> &gt; <a href="4674.htm">7.4.5 Drugs for erectile dysfunction</a> &gt; <a href="74208.htm">Phosphodiesterase type-5 inhibitors</a> &gt; <a href="127954.htm">VARDENAFIL</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="119672.htm" title="Previous: TADALAFIL">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="28351.htm" title="Next: Papaverine and phentolamine">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a303041.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vardenafil Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Cardiovascular Drugs 24:00 &gt; Vasodilating Agents 24:12 &gt; Phosphodiesterase Type 5 Inhibitors 24:12.12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/20645-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Vardenafil</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: V &gt; Interactions of Vardenafil</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="74208.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Phosphodiesterase type-5 inhibitors</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.4 Drugs for genito-urinary disorders &gt; 7.4.5 Drugs for erectile dysfunction</p></div></li><li><a href="127954.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">VARDENAFIL</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.4 Drugs for genito-urinary disorders &gt; 7.4.5 Drugs for erectile dysfunction &gt; Phosphodiesterase type-5 inhibitors</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c103-mn0001-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vardenafil</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-20645-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vardenafil</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Urological Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09935.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Vardenafil</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; V &gt; VA</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E2E3E0R0D107.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Vardenafil</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; V</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_127954">VARDENAFIL</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i967.htm" title="Go to appendix 1">Vardenafil</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">erectile dysfunction</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="target-block: Phosphodiesterase type 5 inhibitor cautions" href="74208.htm#_74208.1">notes above</a>; also elderly; bleeding disorders or active peptic ulceration; susceptibility to prolongation of QT interval (including concomitant use of drugs which prolong QT interval); <b>interactions:</b> Appendix 1 (vardenafil)</p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">see <a title="target-block: Phosphodiesterase type 5 inhibitor contra-indications" href="74208.htm#_74208.2">notes above</a>; also hereditary degenerative retinal disorders</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">initial dose 5 mg in mild to moderate impairment, increased
subsequently according to response (max. 10 mg in moderate impairment);
manufacturer advises avoid in severe impairment</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">initial dose 5 mg if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see <a title="target-text: Phosphodiesterase type-5 inhibitors side-effects - notes" href="74208.htm#_74208.3">notes above</a>; also <i>less commonly</i> drowsiness, dyspnoea, increased lacrimation,
photosensitivity; <i>rarely</i> anxiety, transient amnesia,
hypertonia, and raised intra-ocular pressure</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">See under preparations</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_127955" style="margin: 0 0 0 20px;"><h1 class="title"><sup class="footnote"><a title="Go to footnote" href="127955.htm#footnote113051">(1)</a></sup>Levitra®<span> (<a href="appendix-112803-B.htm#m217751">Bayer</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /> <img class="cJ" src="images/notnhs_l.png" alt="Preparations not available for NHS prescription" /></h1><div class="cAY"><span class="cAB">Tablets</span>, all orange, f/c, vardenafil
(as hydrochloride trihydrate) 5 mg, net price 4-tab pack = £7.56,
8-tab pack = £15.12; 10 mg, 4-tab pack = £14.08, 8-tab pack = £28.16;
20 mg, 4-tab pack = £23.48, 8-tab pack = £46.96<div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF"><span class="cAK">adult</span> over 18 years, initially
10 mg (patients on alpha-blocker therapy 5 mg) approx. 25–60 minutes
before sexual activity, subsequent doses adjusted according to response
up to max. 20 mg as a single dose; max. 1 dose in 24 hours </p><div class="cAV"><h3>Note</h3> <p class="cAX"> Onset of effect may be delayed if taken
with high-fat meal</p></div></div></div></div><div class="cAY"><span class="cAB">Orodispersible tablets</span>, vardenafil
(as hydrochloride) 10 mg, net price 4–tab pack = £17.88<div class="cAQ"><div class="cAO"><span class="cAG">Excipients </span> include aspartame</div><div class="cAF"><h2>Dose</h2> <p class="cAF"><span class="cAK">adult</span> over 18 years, 10 mg
approx. 60 minutes before sexual activity; max. 10 mg in 24 hours
(dose form not suitable for patients with moderate hepatic impairment,
or for initiation of therapy in patients taking alpha-blockers, or
if eGFR less than 30 mL/minute/1.73m<sup>2</sup>)</p></div><p>The <a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="29404.htm#_200790"><i>Scottish Medicines
Consortium</i></a> has advised (September 2011) that vardenafil orodispersible tablets
(<span class="cZ">Levitra</span>®) are accepted for restricted use within
NHS Scotland for men for whom an orodispersible tablet is an appropriate
formulation.</p></div><div class="cAR cAU"><h3>Important</h3> <p class="cAX"><i>Levitra® 10 mg orodispersible</i> tablets and<i> Levitra® 10 mg film coated tablets</i> are <b>not</b> bioequivalent</p></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="119672.htm">Previous: TADALAFIL</a> | <a class="top" href="127955.htm#">Top</a> | <a accesskey="]" href="28351.htm">Next: Papaverine and phentolamine</a> ►</div><div class="cF"><div class="footnote" id="footnote113051"><sup>(1)</sup><img class="cJ" src="images/notnhs_s.png" title="Not prescribable under National Health Service (NHS)" alt="Preparations not available for NHS prescription" /> except to treat erectile dysfunction in men who:<ul class="cBF"><li><p class="cQ">have diabetes, multiple sclerosis, Parkinson’s disease,
poliomyelitis, prostate cancer, severe pelvic injury, single gene
neurological disease, spina bifida, or spinal cord injury;</p></li><li><p class="cQ">are receiving dialysis for renal failure;</p></li><li><p class="cQ">have had radical pelvic surgery, prostatectomy (including
transurethral resection of the prostate), or kidney transplant;</p></li><li><p class="cQ">were receiving <span class="cZ">Caverject</span>®, <span class="cZ">Erecnos</span>®, <span class="cZ">MUSE</span>®, <span class="cZ">Viagra</span>®, or <span class="cZ">Viridal</span>® for erectile dysfunction, at the
expense of the NHS, on 14 September 1998;</p></li><li><p class="cQ">are suffering severe distress as a result of impotence
(prescribed in specialist centres only, see notes above).</p></li></ul><p>The prescription must be endorsed ‘SLS’.</p></div></div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>